The effects of angiotensin-converting enzyme inhibitors in heart recipients: a single center experience

The effects of angiotensin-converting enzyme inhibitors in heart recipients: a single center experience

Aim. To study the effect of ACE inhibitors (ACEI) in heart recipients on the prognosis and myocardial remodeling.Materials and methods. Three hundred and eighty-six patients who received orthotopic heart transplantation (HT) were consequently enrolled to the study from February 2009 to November 2016...

Full description

Bibliographic Details
Main Authors:	А. О. Shevchenko, R. A. Faradzhov, D. A. Izotov, N. N. Koloskova, Е. A. Nikitina, O. E. Gichkun, V. I. Orlov, I. Yu. Tunyaeva, B. L. Mironkov
Format:	Article
Language:	Russian
Published:	Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov 2019-01-01
Series:	Vestnik Transplantologii i Iskusstvennyh Organov
Subjects:	heart transplantation angiotensinconverting enzyme inhibitors survival myocardial remodeling
Online Access:	https://journal.transpl.ru/vtio/article/view/945

Similar Items

Association of Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism with Recurrent Pregnancy Loss: a Meta-Analysis of 26 Case-Control Studies
by: Fereshteh Aslbahar, et al.
Published: (2018-10-01)

Angiotensin converting enzyme inhibitors /
by: DeBrue, Anne N.
Published: (c200)

Serum angiotensin converting enzyme in pemphigus vulgaris
by: Reza M Robati, et al.
Published: (2014-01-01)

Coenzyme Q10 Modulates Remodeling Possibly by Decreasing Angiotensin-Converting Enzyme in Patients with Acute Coronary Syndrome
by: Ram B. Singh, et al.
Published: (2018-07-01)

Angiotensin-converting enzyme inhibitors or sartans in patients at high risk for cardiovascular events: a wrong question or an undesirable answer
by: S R Gilyarevsky, et al.
Published: (2013-03-01)

Increased angiotensin-converting enzyme activity in the left ventricle after infarction
by: V.C.W. Busatto, et al.
Published: (1997-05-01)

Effect of an angiotensin-converting-enzyme inhibitor on the plasma concentration of cytokines and vasoactive molecules in patients with coronary heart disease and hypertension
by: A A Khadartsev, et al.
Published: (2017-12-01)

A continuous fluorescent assay for the determination of plasma and tissue angiotensin I-converting enzyme activity
by: M.F. Alves, et al.
Published: (2005-06-01)

Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis
by: Hyun Woo Lee, et al.
Published: (2021-03-01)

Antecedent Administration of Angiotensin‐Converting Enzyme Inhibitors or Angiotensin II Receptor Antagonists and Survival After Hospitalization for COVID‐19 Syndrome
by: Alberto Palazzuoli, et al.
Published: (2020-11-01)

Angiotensin-converting Enzyme Inhibitors: Can it be a Potential Treatment of Infantile Hemangioma
by: Archika Gupta, et al.
Published: (2021-01-01)

Postoperative angioedema induced by angiotensin-converting enzyme inhibitor: case report
by: Flora Margarida Barra Bisinotto, et al.
Published: (2019-12-01)

Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
by: Carlos P. Vio, et al.
Published: (2020-06-01)

Angiotensin-Converting Enzyme and Heart Failure
by: Sara Álvarez-Zaballos, et al.
Published: (2023-07-01)

Serum Neopterin and Angiotensin-converting Enzyme In Cancer Patients
by: Melichar Bohuslav, et al.
Published: (1994-11-01)

Is there a difference between an angiotensin-converting enzyme inhibitor and an angiotensin-specific receptor blocker for the treatment of hypertension?
by: James A. Ker
Published: (2015-05-01)

Structural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors
by: Daniel eClayton, et al.
Published: (2015-01-01)

Angiotensin-converting enzyme I/D polymorphism in chronic obstructive pulmonary disease
by: Pabst S, et al.
Published: (2009-12-01)

TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS
by: L. N. Malay, et al.
Published: (2016-01-01)

Progress of angiotensin converting enzyme 2 in cardiovascular diseases
by: JIAO Xiao-lu, QIN Yan-wen
Published: (2020-05-01)

RENIN-ANGIOTENSIN SYSTEM IN REGULATION OF HEMATOPOIESIS
by: M. L. Kanaeva, et al.
Published: (2018-02-01)

Angiotensins and rheumatoid arthritis
by: N. M. Savushkina, et al.
Published: (2019-01-01)

Decreased Plasma Levels of Angiotensin-Converting Enzyme Among Patients With Bipolar Disorder
by: Marsal Sanches, et al.
Published: (2021-02-01)

Hyperkalemia Associated with Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blockers in Chronic Kidney Disease
by: Yudi Her Oktaviono, et al.
Published: (2020-04-01)

Hyponatremia Induced by Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers-A Pilot Study
by: S Bhuvaneshwari, et al.
Published: (2018-07-01)

Relating angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers with incidence or mortality of COVID‐19
by: Martin C.S. Wong, et al.
Published: (2020-10-01)

Angiotensin-converting Enzyme Inhibitors-induced Angioedema
by: Chiriac Anca, et al.
Published: (2018-03-01)

Isolated Visceral Angioedema Induced by Angiotensin-Converting Enzyme Inhibitor
by: Ana Maria Oliveira, et al.
Published: (2016-05-01)

Stimulatory effect of dexamethasone on angiotensin-converting enzyme in neonatal rat cardiac myocytes
by: M.L.M. Barreto-Chaves, et al.
Published: (2000-06-01)

Stimulation of Angiotensin Converting Enzyme 2: A Novel Treatment Strategy for Diabetic Nephropathy
by: Haru Nomura, et al.
Published: (2022-01-01)

Angiotensin-Converting Enzyme Gene Insertion/Deletion Polymorphism and Its Association with the Severity of Preeclampsia
by: Özlem Banu Tulmaç, et al.
Published: (2011-12-01)

Association of Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With the Risk of Hospitalization and Death in Hypertensive Patients With COVID‐19
by: Rohan Khera, et al.
Published: (2021-07-01)

A Narrative Review on Nephrotic Syndrome Emphasizing its Correlation With Polymorphism of Angiotensin Converting Enzyme and Renin-Angiotensin System
by: Parisadat Ahmadi, et al.
Published: (2017-04-01)

Effect of renin-angiotensin -aldosterone system blockers on myocardial remodeling processes and risk for atrial fibrillation in patients with arterial hypertension
by: O. M. Drapkina, et al.
Published: (2014-07-01)

Effect of renin-angiotensin -aldosterone system blockers on myocardial remodeling processes and risk for atrial fibrillation in patients with arterial hypertension
by: O. M. Drapkina, et al.
Published: (2014-07-01)

Angiotensin II and COVID-19. Secrets of interactions
by: A. O. Konradi, et al.
Published: (2020-05-01)

Association of Angiotensin Converting Enzyme (ACE) Gene Polymorphism and Diabetic Nephropathy
by: T Golmohamadi, et al.
Published: (2006-09-01)

Effect of angiotensin-converting enzyme inhibitors versus that of angiotensin receptor blockers on survival in patients undergoing hemodialysis: a nationwide observational cohort study
by: Seok Hui Kang, et al.
Published: (2024-12-01)

Urinary Angiotensin Converting Enzyme 2 Increases in Patients With Type 2 Diabetic Mellitus
by: Yaoxian Liang, et al.
Published: (2015-03-01)

Tissue Angiotensin-Converting Enzyme in Patients With Various Clinical Forms of Psoriasis
by: Jasminko Huskić, et al.
Published: (2007-05-01)